Export Alignment
Secondary Structure
None DSSP PSIPRED SSpro
Colour Scheme
Fade Mismatches Enhance Mismatches
Confidencegradient Confidenceclass Indels Chain Unique Chain Rainbow 2° Structure Clustal Hydrophobic Size Charged Polar Proline Ser/Thr Cysteine Aliphatic Aromatic No Colour
Use QMEANBrane values

Background |  |  |

3D Viewer
NGL PV

### Uridylate-specific endoribonuclease nsp15 | P0DTD1 PRO_0000449632

### Created: May 5, 2023, 9:33 p.m. at 21:33

Models | Name | Description | GMQE | QSQE | Seq Id | Coverage | Range | Method | Resolution | Oligo-state | Ligands | Found by | Seq Similarity
| 7k9p.1.A | Uridylate-specific endoribonuclease Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.87 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k9p.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k9p.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k9p.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k9p.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k9p.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k9p.1.B | Uridylate-specific endoribonuclease Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.87 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k9p.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k9p.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k9p.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k9p.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k9p.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k9p.1.C | Uridylate-specific endoribonuclease Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.87 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k9p.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k9p.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k9p.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k9p.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k9p.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k9p.1.D | Uridylate-specific endoribonuclease Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.88 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k9p.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k9p.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k9p.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k9p.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k9p.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k9p.1.E | Uridylate-specific endoribonuclease Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.88 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k9p.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k9p.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k9p.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k9p.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k9p.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k9p.1.F | Uridylate-specific endoribonuclease Room temperature structure of NSP15 Endoribonuclease from SARS CoV-2 solved using SFX. | 0.97 | 0.88 | 100.00 | 1.00 | 1-346 | X-ray | 2.60 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k9p.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k9p.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k9p.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k9p.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k9p.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6x.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 | 0.89 | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6x.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6x.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6x.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6x.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6x.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6x.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 | 0.89 | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6x.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6x.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6x.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6x.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6x.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6x.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6x.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6x.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6x.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6x.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6x.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6x.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6x.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6x.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6x.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6x.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6x.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6x.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6x.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6x.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6x.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6x.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6x.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6x.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2889976755 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6x.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6x.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6x.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6x.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6x.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6y.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6y.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6y.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6y.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6y.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6y.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z56900771 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.32 | homo-hexamer | 6 x WUJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6z.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6z.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6z.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6z.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6z.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6z.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6z.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6z.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6z.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6z.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6z.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6z.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6z.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6z.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6z.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6z.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6z.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6z.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6z.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6z.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6z.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6z.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6z.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6z.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6z.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6z.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6z.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6z.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6z.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6z.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s6z.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with PB2255187532 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.28 | homo-hexamer | 6 x WUM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s6z.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s6z.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s6z.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s6z.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s6z.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s70.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s70.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s70.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s70.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s70.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s70.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s70.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s70.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s70.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s70.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s70.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s70.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s70.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s70.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s70.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s70.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s70.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s70.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s70.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s70.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s70.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s70.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s70.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s70.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s70.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s70.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s70.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s70.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s70.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s70.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s70.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-181428 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.33 | homo-hexamer | 3 x WUS | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s70.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s70.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s70.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s70.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s70.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keg.1.A | Uridylate-specific endoribonuclease Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keg.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keg.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keg.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keg.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keg.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keh.1.D | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keh.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keh.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keh.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keh.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keh.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keh.1.F | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keh.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keh.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keh.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keh.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keh.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keg.1.D | Uridylate-specific endoribonuclease Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keg.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keg.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keg.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keg.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keg.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s71.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s71.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s71.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s71.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s71.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s71.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keg.1.C | Uridylate-specific endoribonuclease Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keg.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keg.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keg.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keg.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keg.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keg.1.F | Uridylate-specific endoribonuclease Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keg.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keg.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keg.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keg.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keg.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keh.1.E | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keh.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keh.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keh.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keh.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keh.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7kf4.1.C | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7kf4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7kf4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7kf4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7kf4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7kf4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7kf4.1.B | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7kf4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7kf4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7kf4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7kf4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7kf4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keh.1.A | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keh.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keh.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keh.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keh.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keh.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s71.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s71.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s71.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s71.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s71.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s71.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7kf4.1.E | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7kf4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7kf4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7kf4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7kf4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7kf4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s71.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s71.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s71.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s71.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s71.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s71.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keh.1.C | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keh.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keh.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keh.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keh.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keh.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s71.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s71.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s71.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s71.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s71.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s71.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keg.1.E | Uridylate-specific endoribonuclease Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keg.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keg.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keg.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keg.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keg.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s71.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s71.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s71.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s71.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s71.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s71.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keg.1.B | Uridylate-specific endoribonuclease Crystal structure from SARS-COV2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keg.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keg.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keg.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keg.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keg.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7kf4.1.A | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7kf4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7kf4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7kf4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7kf4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7kf4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s71.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with FUZS-5 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.94 | homo-hexamer | 6 x WUV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s71.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s71.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s71.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s71.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s71.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7keh.1.B | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.59 | homo-hexamer | 6 x B3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7keh.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7keh.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7keh.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7keh.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7keh.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s72.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s72.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s72.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s72.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s72.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s72.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s72.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s72.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s72.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s72.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s72.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s72.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s72.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s72.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s72.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s72.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s72.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s72.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s72.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s72.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s72.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s72.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s72.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s72.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s72.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s72.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s72.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s72.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s72.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s72.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5s72.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with BBL029427 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.51 | homo-hexamer | 3 x WUY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5s72.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5s72.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5s72.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5s72.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5s72.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sad.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sad.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sad.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sad.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sad.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sad.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sad.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sad.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sad.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sad.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sad.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sad.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saa.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saa.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saa.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saa.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saa.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saa.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa4.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saa.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saa.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saa.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saa.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saa.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saa.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sac.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sac.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sac.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sac.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sac.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sac.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saa.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saa.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saa.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saa.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saa.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saa.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa4.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saf.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sag.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sag.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sag.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sag.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sag.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sag.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sae.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sae.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sae.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sae.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sae.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sae.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sah.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sah.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sah.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sah.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sah.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sah.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sai.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sai.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sai.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sai.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sai.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sai.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sah.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sah.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sah.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sah.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sah.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sah.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa7.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa7.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa7.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa7.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa7.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa7.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sai.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sai.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sai.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sai.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sai.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sai.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa5.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa5.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa5.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa5.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa5.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa5.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sah.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sah.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sah.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sah.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sah.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sah.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sab.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sab.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sab.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sab.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sab.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sab.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa9.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa9.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa9.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa9.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa9.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa9.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sai.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sai.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sai.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sai.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sai.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sai.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sah.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sah.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sah.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sah.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sah.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sah.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sae.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sae.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sae.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sae.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sae.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sae.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saf.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sag.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sag.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sag.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sag.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sag.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sag.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa5.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa5.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa5.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa5.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa5.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa5.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sab.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sab.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sab.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sab.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sab.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sab.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa9.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa9.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa9.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa9.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa9.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa9.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sac.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sac.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sac.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sac.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sac.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sac.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sag.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sag.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sag.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sag.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sag.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sag.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa7.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa7.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa7.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa7.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa7.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa7.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sab.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sab.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sab.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sab.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sab.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sab.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saf.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa7.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa7.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa7.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa7.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa7.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa7.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sae.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sae.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sae.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sae.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sae.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sae.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sae.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sae.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sae.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sae.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sae.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sae.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saa.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saa.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saa.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saa.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saa.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saa.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sah.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sah.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sah.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sah.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sah.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sah.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa4.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sab.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sab.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sab.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sab.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sab.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sab.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa4.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa9.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa9.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa9.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa9.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa9.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa9.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sac.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sac.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sac.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sac.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sac.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sac.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sab.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sab.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sab.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sab.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sab.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sab.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa5.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa5.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa5.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa5.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa5.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa5.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa6.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa6.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa6.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa6.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa6.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa6.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa9.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa9.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa9.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa9.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa9.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa9.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa9.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa9.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa9.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa9.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa9.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa9.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa5.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa5.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa5.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa5.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa5.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa5.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sab.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z31504642 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.49 | homo-hexamer | 3 x WJD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sab.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sab.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sab.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sab.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sab.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sac.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sac.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sac.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sac.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sac.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sac.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saf.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sad.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sad.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sad.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sad.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sad.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sad.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sae.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sae.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sae.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sae.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sae.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sae.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa5.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa5.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa5.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa5.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa5.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa5.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa8.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa8.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa8.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa8.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa8.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa8.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa7.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa7.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa7.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa7.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa7.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa7.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sac.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sac.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sac.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sac.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sac.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sac.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa8.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa8.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa8.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa8.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa8.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa8.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa6.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa6.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa6.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa6.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa6.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa6.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa5.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1530301542 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 3 x ZQA | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa5.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa5.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa5.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa5.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa5.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sac.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z59181945 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.03 | homo-hexamer | 3 x VWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sac.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sac.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sac.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sac.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sac.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sag.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sag.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sag.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sag.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sag.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sag.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sad.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sad.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sad.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sad.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sad.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sad.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sai.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sai.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sai.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sai.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sai.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sai.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sad.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sad.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sad.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sad.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sad.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sad.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa6.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa6.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa6.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa6.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa6.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa6.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saf.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sad.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z425449682 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.96 | homo-hexamer | 3 x EJW | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sad.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sad.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sad.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sad.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sad.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sae.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z3219959731 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.12 | homo-hexamer | 6 x W3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sae.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sae.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sae.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sae.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sae.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sai.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sai.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sai.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sai.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sai.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sai.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saf.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-321461 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.11 | homo-hexamer | 6 x WOY | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saa.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saa.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saa.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saa.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saa.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saa.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sai.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1424343998 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.02 | homo-hexamer | 3 x ZQM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sai.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sai.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sai.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sai.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sai.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa6.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa6.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa6.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa6.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa6.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa6.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sag.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sag.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sag.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sag.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sag.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sag.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa6.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa6.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa6.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa6.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa6.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa6.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa4.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa7.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa7.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa7.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa7.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa7.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa7.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa8.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa8.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa8.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa8.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa8.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa8.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sah.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-100112 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.16 | homo-hexamer | 6 x ZQJ | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sah.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sah.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sah.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sah.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sah.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa8.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa8.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa8.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa8.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa8.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa8.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5saa.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z319891284 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.24 | homo-hexamer | 6 x ZQD | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5saa.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5saa.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5saa.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5saa.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5saa.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sag.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with EN300-1605072 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.88 | homo-hexamer | 3 x ZQG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sag.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sag.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sag.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sag.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sag.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa4.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z239136710 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.05 | homo-hexamer | 3 x K3A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa8.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa8.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa8.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa8.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa8.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa8.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa6.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2856434783 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.52 | homo-hexamer | 6 x O3G | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa6.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa6.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa6.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa6.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa6.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa9.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z2697514548 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.92 | homo-hexamer | 3 x GWG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa9.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa9.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa9.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa9.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa9.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa8.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z68299550 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.30 | homo-hexamer | 6 x JOV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa8.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa8.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa8.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa8.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa8.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sa7.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NendoU in complex with Z1673618163 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.22 | homo-hexamer | 3 x WL7 | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sa7.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sa7.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sa7.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sa7.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sa7.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7y.1.A | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7w.1.B | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7w.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7w.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7w.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7w.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7w.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7u.1.B | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7u.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7u.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7u.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7u.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7u.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7w.1.F | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7w.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7w.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7w.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7w.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7w.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n83.1.E | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n83.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n83.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n83.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n83.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n83.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n83.1.F | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n83.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n83.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n83.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n83.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n83.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7u.1.F | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7u.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7u.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7u.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7u.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7u.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7u.1.C | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7u.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7u.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7u.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7u.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7u.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n83.1.A | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n83.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n83.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n83.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n83.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n83.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n83.1.C | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n83.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n83.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n83.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n83.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n83.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7y.1.C | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n83.1.D | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n83.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n83.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n83.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n83.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n83.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7u.1.E | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7u.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7u.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7u.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7u.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7u.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7u.1.A | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7u.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7u.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7u.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7u.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7u.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7y.1.D | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7y.1.B | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n83.1.B | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2443429438 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.91 | homo-hexamer | 21 x WNM | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n83.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n83.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n83.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n83.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n83.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7u.1.D | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with LIZA-7 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.06 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7u.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7u.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7u.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7u.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7u.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7y.1.F | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7w.1.C | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7w.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7w.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7w.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7w.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7w.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7w.1.E | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7w.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7w.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7w.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7w.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7w.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7w.1.A | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7w.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7w.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7w.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7w.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7w.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7w.1.D | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with CSC000178569 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.42 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7w.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7w.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7w.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7w.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7w.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7y.1.E | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z18197050 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.09 | homo-hexamer | 6 x RZG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7y.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7y.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7y.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7y.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7y.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7r.1.F | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7r.1.A | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7r.1.B | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7r.1.D | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7r.1.E | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n7r.1.C | Uridylate-specific endoribonuclease Crystal Structure of SARS-CoV-2 NendoU in complex with Z2472938267 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.01 | homo-hexamer | 3 x S6V | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n7r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n7r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n7r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n7r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n7r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sbf.1.E | Uridylate-specific endoribonuclease PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sbf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sbf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sbf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sbf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sbf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sbf.1.B | Uridylate-specific endoribonuclease PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sbf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sbf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sbf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sbf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sbf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sbf.1.A | Uridylate-specific endoribonuclease PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sbf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sbf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sbf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sbf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sbf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sbf.1.F | Uridylate-specific endoribonuclease PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sbf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sbf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sbf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sbf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sbf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sbf.1.D | Uridylate-specific endoribonuclease PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sbf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sbf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sbf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sbf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sbf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 5sbf.1.C | Uridylate-specific endoribonuclease PanDDA analysis group deposition of ground-state model of SARS-CoV-2 NendoU | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.64 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5sbf.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5sbf.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    5sbf.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    5sbf.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    5sbf.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7kf4.1.D | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7kf4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7kf4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7kf4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7kf4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7kf4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7kf4.1.F | Uridylate-specific endoribonuclease Crystal structure from SARS-CoV-2 NendoU NSP15 | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.61 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7kf4.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7kf4.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7kf4.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7kf4.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7kf4.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb2.1.D | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb2.1.F | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb2.1.A | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb2.1.B | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb2.1.C | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb2.1.E | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU in BIS-Tris pH 6.0 | 0.97 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb0.1.D | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.94 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb0.1.F | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.95 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb0.1.C | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.95 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb0.1.E | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.94 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb0.1.A | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.95 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7rb0.1.B | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 7.5 | 0.95 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7rb0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7rb0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7rb0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7rb0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7rb0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k0r.1.A | Uridylate-specific endoribonuclease Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k0r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k0r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k0r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k0r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k0r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k0r.1.B | Uridylate-specific endoribonuclease Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k0r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k0r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k0r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k0r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k0r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k0r.1.C | Uridylate-specific endoribonuclease Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k0r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k0r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k0r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k0r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k0r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k0r.1.D | Uridylate-specific endoribonuclease Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k0r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k0r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k0r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k0r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k0r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k0r.1.E | Uridylate-specific endoribonuclease Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k0r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k0r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k0r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k0r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k0r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k0r.1.F | Uridylate-specific endoribonuclease Nucleotide bound SARS-CoV-2 Nsp15 | 0.99 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k0r.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k0r.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k0r.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k0r.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k0r.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7me0.1.A | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7me0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7me0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7me0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7me0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7me0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7me0.1.B | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7me0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7me0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7me0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7me0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7me0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7me0.1.C | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7me0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7me0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7me0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7me0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7me0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7me0.1.D | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7me0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7me0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7me0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7me0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7me0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7me0.1.E | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7me0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7me0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7me0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7me0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7me0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7me0.1.F | Uridylate-specific endoribonuclease Cryo-EM structure of SARS-CoV-2 NSP15 NendoU at pH 6.0 | 0.98 |  | 100.00 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7me0.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7me0.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7me0.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7me0.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7me0.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6xdh.1.A | Uridylate-specific endoribonuclease Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6xdh.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6xdh.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6xdh.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6xdh.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6xdh.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6xdh.1.B | Uridylate-specific endoribonuclease Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6xdh.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6xdh.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6xdh.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6xdh.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6xdh.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6xdh.1.C | Uridylate-specific endoribonuclease Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6xdh.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6xdh.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6xdh.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6xdh.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6xdh.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6xdh.2.A | Uridylate-specific endoribonuclease Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6xdh.2    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6xdh.2    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6xdh.2    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6xdh.2    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6xdh.2    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6xdh.2.B | Uridylate-specific endoribonuclease Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6xdh.2    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6xdh.2    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6xdh.2    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6xdh.2    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6xdh.2    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6xdh.2.C | Uridylate-specific endoribonuclease Crystal Structure of NendoU (Uridylate-specific endoribonuclease, nsp15) from Betacoronavirus SARS-CoV-2 | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.35 | homo-trimer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6xdh.2    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6xdh.2    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6xdh.2    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6xdh.2    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6xdh.2    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6vww.1.F | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6vww.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6vww.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6vww.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6vww.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6vww.1    TIDYTEISFMLWCKDGHVETFYPKLQ
✓ | 6w01.1.A | Uridylate-specific endoribonuclease The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 | 0.92 | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6w01.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6w01.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6w01.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6w01.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6w01.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6w01.1.D | Uridylate-specific endoribonuclease The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6w01.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6w01.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6w01.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6w01.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6w01.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6vww.1.A | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6vww.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6vww.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6vww.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6vww.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6vww.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6w01.1.E | Uridylate-specific endoribonuclease The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6w01.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6w01.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6w01.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6w01.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6w01.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6vww.1.E | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6vww.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6vww.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6vww.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6vww.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6vww.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6w01.1.F | Uridylate-specific endoribonuclease The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6w01.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6w01.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6w01.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6w01.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6w01.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6w01.1.B | Uridylate-specific endoribonuclease The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6w01.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6w01.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6w01.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6w01.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6w01.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6w01.1.C | Uridylate-specific endoribonuclease The 1.9 A Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with a Citrate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.90 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6w01.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6w01.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6w01.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6w01.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6w01.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6vww.1.D | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6vww.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6vww.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6vww.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6vww.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6vww.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6vww.1.B | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6vww.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6vww.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6vww.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6vww.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6vww.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6vww.1.C | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2. | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.20 | homo-hexamer | 3 x MG | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6vww.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6vww.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6vww.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6vww.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6vww.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1o.1.F | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1o.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1o.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1o.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1o.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1o.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1o.1.E | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1o.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1o.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1o.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1o.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1o.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1o.1.C | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1o.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1o.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1o.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1o.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1o.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1o.1.B | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1o.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1o.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1o.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1o.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1o.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1o.1.A | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1o.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1o.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1o.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1o.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1o.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1o.1.D | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-3',5'-Diphosphate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.40 | homo-hexamer | 6 x VQV | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1o.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1o.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1o.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1o.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1o.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6wlc.1.E | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wlc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wlc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wlc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wlc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wlc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x1b.1.D | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x1b.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x1b.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x1b.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x1b.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x1b.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x4i.1.D | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x4i.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x4i.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x4i.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x4i.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x4i.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6wxc.1.B | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wxc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wxc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wxc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wxc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wxc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x4i.1.A | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x4i.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x4i.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x4i.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x4i.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x4i.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6wxc.1.C | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wxc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wxc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wxc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wxc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wxc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1l.1.A | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1l.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1l.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1l.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1l.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1l.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x1b.1.B | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x1b.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x1b.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x1b.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x1b.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x1b.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x4i.1.B | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x4i.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x4i.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x4i.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x4i.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x4i.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1l.1.C | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1l.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1l.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1l.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1l.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1l.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6wxc.1.E | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wxc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wxc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wxc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wxc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wxc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6wlc.1.B | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wlc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wlc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wlc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wlc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wlc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6wxc.1.A | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wxc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wxc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wxc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wxc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wxc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6wxc.1.F | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wxc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wxc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wxc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wxc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wxc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6wlc.1.F | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wlc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wlc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wlc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wlc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wlc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x4i.1.E | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x4i.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x4i.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x4i.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x4i.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x4i.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x1b.1.F | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x1b.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x1b.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x1b.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x1b.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x1b.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x4i.1.F | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x4i.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x4i.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x4i.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x4i.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x4i.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6wlc.1.D | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wlc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wlc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wlc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wlc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wlc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1l.1.E | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1l.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1l.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1l.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1l.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1l.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6wlc.1.C | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wlc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wlc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wlc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wlc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wlc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1l.1.F | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1l.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1l.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1l.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1l.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1l.1    TIDYTEISFMLWCKDGHVETFYPKLQ
✓ | 6wlc.1.A | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-5'-Monophosphate | 0.99 | 0.92 | 100.00 | 1.00 | 1-346 | X-ray | 1.82 | homo-hexamer | 6 x U5P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wlc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wlc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wlc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wlc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wlc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1l.1.D | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1l.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1l.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1l.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1l.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1l.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6wxc.1.D | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with potential repurposing drug Tipiracil | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x CMU | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6wxc.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6wxc.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6wxc.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6wxc.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6wxc.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x4i.1.C | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with 3'-uridinemonophosphate | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.85 | homo-hexamer | 6 x U3P | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x4i.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x4i.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x4i.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x4i.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x4i.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7k1l.1.B | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with Uridine-2',3'-Vanadate | 0.98 |  | 100.00 | 1.00 | 1-346 | X-ray | 2.25 | homo-hexamer | 6 x UVC | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7k1l.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7k1l.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7k1l.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7k1l.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7k1l.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x1b.1.A | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x1b.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x1b.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x1b.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x1b.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x1b.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x1b.1.E | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x1b.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x1b.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x1b.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x1b.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x1b.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 6x1b.1.C | Uridylate-specific endoribonuclease Crystal Structure of NSP15 Endoribonuclease from SARS CoV-2 in the Complex with the Product Nucleotide GpU. | 0.99 |  | 100.00 | 1.00 | 1-346 | X-ray | 1.97 | homo-hexamer | 6 x G-U | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    6x1b.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    6x1b.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    6x1b.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    6x1b.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    6x1b.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tqv.1.A | Uridylate-specific endoribonuclease SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tqv.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tqv.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tqv.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tqv.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tqv.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tqv.1.B | Uridylate-specific endoribonuclease SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tqv.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tqv.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tqv.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tqv.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tqv.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tqv.1.C | Uridylate-specific endoribonuclease SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tqv.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tqv.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tqv.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tqv.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tqv.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tqv.1.D | Uridylate-specific endoribonuclease SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tqv.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tqv.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tqv.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tqv.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tqv.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tqv.1.E | Uridylate-specific endoribonuclease SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tqv.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tqv.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tqv.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tqv.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tqv.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tqv.1.F | Uridylate-specific endoribonuclease SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tqv.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tqv.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tqv.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tqv.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tqv.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tj2.1.A | Uridylate-specific endoribonuclease nsp15 SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tj2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tj2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tj2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tj2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tj2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tj2.1.B | Uridylate-specific endoribonuclease nsp15 SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tj2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tj2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tj2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tj2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tj2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tj2.1.C | Uridylate-specific endoribonuclease nsp15 SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tj2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tj2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tj2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tj2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tj2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tj2.1.D | Uridylate-specific endoribonuclease nsp15 SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.81 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tj2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tj2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tj2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tj2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tj2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tj2.1.E | Uridylate-specific endoribonuclease nsp15 SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.97 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tj2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tj2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tj2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tj2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tj2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7tj2.1.F | Uridylate-specific endoribonuclease nsp15 SARS-CoV-2 endoribonuclease Nsp15 bound to dsRNA | 0.96 |  | 99.71 | 1.00 | 1-346 | EM | 0.00 | homo-hexamer |  | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7tj2.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7tj2.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7tj2.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7tj2.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7tj2.1    TIDYTEISFMLWCKDGHVETFYPKLQ
| 7n06.1.A | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.99 |  | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n06.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n06.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n06.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n06.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n06.1    TIDYTEISFMLWCKDGHVETFYPKL-
| 7n06.1.B | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.99 |  | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n06.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n06.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n06.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n06.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n06.1    TIDYTEISFMLWCKDGHVETFYPKL-
| 7n06.1.C | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.99 |  | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n06.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n06.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n06.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n06.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n06.1    TIDYTEISFMLWCKDGHVETFYPKL-
| 7n06.1.D | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.98 |  | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n06.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n06.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n06.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n06.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n06.1    TIDYTEISFMLWCKDGHVETFYPKL-
| 7n06.1.E | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.98 |  | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n06.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n06.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n06.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n06.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n06.1    TIDYTEISFMLWCKDGHVETFYPKL-
| 7n06.1.F | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease post-cleavage state | 0.98 |  | 100.00 | 1.00 | 1-345 | EM | 0.00 | homo-hexamer | 6 x A-U-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n06.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n06.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n06.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n06.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n06.1    TIDYTEISFMLWCKDGHVETFYPKL-
| 7n33.1.A | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 |  | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n33.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n33.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n33.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n33.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n33.1    TIDYTEISFMLWCKDGHVETFYPK--
| 7n33.1.B | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 |  | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n33.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n33.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n33.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n33.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n33.1    TIDYTEISFMLWCKDGHVETFYPK--
| 7n33.1.C | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 |  | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n33.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n33.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n33.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n33.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n33.1    TIDYTEISFMLWCKDGHVETFYPK--
| 7n33.1.D | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 |  | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n33.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n33.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n33.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n33.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n33.1    TIDYTEISFMLWCKDGHVETFYPK--
| 7n33.1.E | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 |  | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n33.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n33.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n33.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n33.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n33.1    TIDYTEISFMLWCKDGHVETFYPK--
| 7n33.1.F | Uridylate-specific endoribonuclease SARS-CoV-2 Nsp15 endoribonuclease pre-cleavage state | 0.98 |  | 100.00 | 0.99 | 1-344 | EM | 0.00 | homo-hexamer | 6 x UFT-A | HHblits | 0.61
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    7n33.1    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    7n33.1    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    7n33.1    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    7n33.1    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    7n33.1    TIDYTEISFMLWCKDGHVETFYPK--
| 2ozk.1.A | Uridylate-specific endoribonuclease Structure of an N-Terminal Truncated Form of Nendou (NSP15) From SARS-CORONAVIRUS | 0.83 | 0.59 | 88.73 | 1.00 | 1-346 | X-ray | 2.90 | homo-tetramer |  | HHblits | 0.58
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2ozk.1    SLENVAYNVVNKGHFDGHAGEAPVSIINNAVYTKVDGIDVEIFENKTTLPVNVAFELWAKRNIKPVPEIKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2ozk.1    ANTVIWDYKREAPAHVSTIGVCTMTDIAKKPTESACSSLTVLFDGRVEGQVDLFRNARNGVLITEGSVKGLTPSKGPAQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    2ozk.1    SVNGVTLIGESVKTQFNYFKKVDGIIQQLPETYFTQSRDLEDFKPRSQMETDFLELAMDEFIQRYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    2ozk.1    SHGQLGGLHLMIGLAKRSQDSPLKLEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVISKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    2ozk.1    TIDYAEISFMLWCKDGHVETFYPKLQ
| 2ozk.1.C | Uridylate-specific endoribonuclease Structure of an N-Terminal Truncated Form of Nendou (NSP15) From SARS-CORONAVIRUS | 0.79 | 0.57 | 88.73 | 1.00 | 1-346 | X-ray | 2.90 | homo-tetramer |  | HHblits | 0.58
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2ozk.1    SLENVAYNVVNKGHFDGHAGEAPVSIINNAVYTKVDGIDVEIFENKTTLPVNVAFELWAKRNIKPVPEIKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2ozk.1    ANTVIWDYKREAPAHVSTIGVCTMTDIAKKPTESACSSLTVLFDGRVEGQVDLFRNARNGVLITEGSVKGLTPSKGPAQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    2ozk.1    SVNGVTLIGESVKTQFNYFKKVDGIIQQLPETYFTQSRDLEDFKPRSQMETDFLELAMDEFIQRYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    2ozk.1    SHGQLGGLHLMIGLAKRSQDSPLKLEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVISKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    2ozk.1    TIDYAEISFMLWCKDGHVETFYPKLQ
| 2ozk.1.D | Uridylate-specific endoribonuclease Structure of an N-Terminal Truncated Form of Nendou (NSP15) From SARS-CORONAVIRUS | 0.79 | 0.58 | 88.73 | 1.00 | 1-346 | X-ray | 2.90 | homo-tetramer |  | HHblits | 0.58
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2ozk.1    SLENVAYNVVNKGHFDGHAGEAPVSIINNAVYTKVDGIDVEIFENKTTLPVNVAFELWAKRNIKPVPEIKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2ozk.1    ANTVIWDYKREAPAHVSTIGVCTMTDIAKKPTESACSSLTVLFDGRVEGQVDLFRNARNGVLITEGSVKGLTPSKGPAQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    2ozk.1    SVNGVTLIGESVKTQFNYFKKVDGIIQQLPETYFTQSRDLEDFKPRSQMETDFLELAMDEFIQRYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    2ozk.1    SHGQLGGLHLMIGLAKRSQDSPLKLEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVISKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    2ozk.1    TIDYAEISFMLWCKDGHVETFYPKLQ
✓ | 2rhb.1.A | Uridylate-specific endoribonuclease Crystal structure of Nsp15-H234A mutant- Hexamer in asymmetric unit | 0.96 | 0.88 | 88.44 | 1.00 | 1-346 | X-ray | 2.80 | homo-hexamer |  | HHblits | 0.58
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2rhb.1    SLENVAYNVVNKGHFDGHAGEAPVSIINNAVYTKVDGIDVEIFENKTTLPVNVAFELWAKRNIKPVPEIKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2rhb.1    ANTVIWDYKREAPAHVSTIGVCTMTDIAKKPTESACSSLTVLFDGRVEGQVDLFRNARNGVLITEGSVKGLTPSKGPAQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    2rhb.1    SVNGVTLIGESVKTQFNYFKKVDGIIQQLPETYFTQSRDLEDFKPRSQMETDFLELAMDEFIQRYKLEGYAFEAIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    2rhb.1    SHGQLGGLHLMIGLAKRSQDSPLKLEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVISKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    2rhb.1    TIDYAEISFMLWCKDGHVETFYPKLQ
✓ | 2h85.1.A | Putative orf1ab polyprotein Crystal Structure of Nsp 15 from SARS | 0.96 | 0.87 | 88.12 | 1.00 | 1-345 | X-ray | 2.60 | homo-hexamer |  | HHblits | 0.58
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2h85.1    SLENVAYNVVNKGHFDGHAGEAPVSIINNAVYTKVDGIDVEIFENKTTLPVNVAFELWAKRNIKPVPEIKILNNLGVDIA

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2h85.1    ANTVIWDYKREAPAHVSTIGVCTMTDIAKKPTESACSSLTVLFDGRVEGQVDLFRNARNGVLITEGSVKGLTPSKGPAQA

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    2h85.1    SVNGVTLIGESVKTQFNYFKKVDGIIQQLPETYFTQSRDLEDFKPRSQMETDFLELAMDEFIQRYKLEGYAFEHIVYGDF

    target    SHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKV
    2h85.1    SHGQLGGLHLMIGLAKRSQDSPLKLEDFIPMDSTVKNYFITDAQTGSSKCGCSVIDLLLGDFVEIIKSQDLSVISKVVKV

    target    TIDYTEISFMLWCKDGHVETFYPKLQ
    2h85.1    TIDYAEISFMLWCKDGHVETFYPKL-
| 5yvd.1.A | Nsp15 Structural and biochemical characterization of endoribonuclease Nsp15 encoded by Middle East Respiratory Syndrome Coronavirus | 0.80 |  | 52.21 | 0.98 | 2-346 | X-ray | 2.70 | homo-hexamer |  | BLAST | 0.44
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5yvd.1    -LENIAFNVVKQGHFIGVEGELPVAVVNDKIFTKSGVNDICMFENKTTLPTNIAFELYAKRAVRSHPDFKLLHNLQADIC

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5yvd.1    YKFVLWDYERSNIYGTATIGVCKYTDIDVNSALNIC------FDIRDNCSLEKFMSTPNAIFISDRKIKKYPCMVGPDYA

    target    SLNGVTLIGEAVKTQ---FNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVY
    5yvd.1    YFNGAIIRDSDVVKQPVKFYLYKKVNNEFIDPTECIYTQSRSCSDFLPLSDMEKDFLSFDSDVFIKKYGLENYAFEHVVY

    target    GDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKV
    5yvd.1    GDFSHTTLGGLHLLIGLYKRQQEGHIIMEEMLKGSSTIHNYFITETNTAAFKAVCSVIDLKLDDFVMILKSQDLGVVSKV

    target    VKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5yvd.1    VKVPIDLTMIEFMLWCKDGQVQTFYPRLQ
| 5yvd.1.A | Nsp15 Structural and biochemical characterization of endoribonuclease Nsp15 encoded by Middle East Respiratory Syndrome Coronavirus | 0.81 |  | 51.18 | 0.98 | 1-346 | X-ray | 2.70 | homo-hexamer |  | HHblits | 0.44
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5yvd.1    GLENIAFNVVKQGHFIGVEGELPVAVVNDKIFTKSGVNDICMFENKTTLPTNIAFELYAKRAVRSHPDFKLLHNLQADIC

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5yvd.1    YKFVLWDYERSNIYGTATIGVCKYTDIDV------NSALNICFDIRDNCSLEKFMSTPNAIFISDRKIKKYPCMVGPDYA

    target    SLNGVTLIGE---AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVY
    5yvd.1    YFNGAIIRDSDVVKQPVKFYLYKKVNNEFIDPTECIYTQSRSCSDFLPLSDMEKDFLSFDSDVFIKKYGLENYAFEHVVY

    target    GDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKV
    5yvd.1    GDFSHTTLGGLHLLIGLYKRQQEGHIIMEEMLKGSSTIHNYFITETNTAAFKAVCSVIDLKLDDFVMILKSQDLGVVSKV

    target    VKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5yvd.1    VKVPIDLTMIEFMLWCKDGQVQTFYPRLQ
| 2gth.1.A | Replicase polyprotein 1ab crystal structure of the wildtype MHV coronavirus non-structural protein nsp15 | 0.76 |  | 49.55 | 0.97 | 1-341 | X-ray | 2.70 | homo-hexamer |  | BLAST | 0.44
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2gth.1    SLENVVYNLVNAGHFDGRAGELPCAVIGEKVIAKIQNEDVVVFKNNTPFPTNVAVELFAKRSIRPHPELKLFRNLNIDVC

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2gth.1    WSHVLWDYAKDSVFCSSTYKVCKYTDL------QCIESLNVLFDGRDNGALEAFKKCRNGVYINTTKIKSLSMIKGPQRA

    target    SLNGVTL--IGEA-VKTQFNYYKKVDGVV-----------QQLPE--------------------TYFTQSRNLQEFKPR
    2gth.1    DLNGVVVEKVGDSDVEFWFAVRKDGDDVIFSRTGSLEPSHYRSPQGNPGGNRVGDLSGNEALARGTIFTQSRLLSSFTPR

    target    SQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    2gth.1    SEMEKDFMDLDDDVFIAKYSLQDYAFEHVVYGSFNQKIIGGLHLLIGLARRQQKSNLVIQEFVTYDSSIHSYFITDENSG

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    2gth.1    SSKSVCTVIDLLLDDFVDIVKSLNLKCVSKVVNVNVDFKDFQFMLWCNEEKVMTF-----
| 2gti.1.A | Replicase polyprotein 1ab mutation of MHV coronavirus non-structural protein nsp15 (F307L) | 0.77 |  | 49.25 | 0.97 | 1-341 | X-ray | 2.15 | homo-hexamer |  | BLAST | 0.44
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2gti.1    SLENVVYNLVNAGHFDGRAGELPCAVIGEKVIAKIQNEDVVVFKNNTPFPTNVAVELFAKRSIRPHPELKLFRNLNIDVC

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2gti.1    WSHVLWDYAKDSVFCSSTYKVCKYTDL------QCIESLNVLFDGRDNGALEAFKKCRNGVYINTTKIKSLSMIKGPQRA

    target    SLNGVTL--IGEA-VKTQFNYYKKVDGVV-----------QQLPE--------------------TYFTQSRNLQEFKPR
    2gti.1    DLNGVVVEKVGDSDVEFWFAVRKDGDDVIFSRTGSLEPSHYRSPQGNPGGNRVGDLSGNEALARGTIFTQSRLLSSFTPR

    target    SQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    2gti.1    SEMEKDFMDLDDDVFIAKYSLQDYAFEHVVYGSFNQKIIGGLHLLIGLARRQQKSNLVIQEFVTYDSSIHSYLITDENSG

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    2gti.1    SSKSVCTVIDLLLDDFVDIVKSLNLKCVSKVVNVNVDFKDFQFMLWCNEEKVMTF-----
| 2gth.1.A | Replicase polyprotein 1ab crystal structure of the wildtype MHV coronavirus non-structural protein nsp15 | 0.78 |  | 48.36 | 0.97 | 1-341 | X-ray | 2.70 | homo-hexamer |  | HHblits | 0.43
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2gth.1    SLENVVYNLVNAGHFDGRAGELPCAVIGEKVIAKIQNEDVVVFKNNTPFPTNVAVELFAKRSIRPHPELKLFRNLNIDVC

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2gth.1    WSHVLWDYAKDSVFCSSTYKVCKYTDLQC------IESLNVLFDGRDNGALEAFKKCRNGVYINTTKIKSLSMIKGPQRA

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLP---------------------------------ETYFTQSRNLQEFKPR
    2gth.1    DLNGVVVEKVGDSDVEFWFAVRKDGDDVIFSRTGSLEPSHYRSPQGNPGGNRVGDLSGNEALARGTIFTQSRLLSSFTPR

    target    SQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    2gth.1    SEMEKDFMDLDDDVFIAKYSLQDYAFEHVVYGSFNQKIIGGLHLLIGLARRQQKSNLVIQEFVTYDSSIHSYFITDENSG

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    2gth.1    SSKSVCTVIDLLLDDFVDIVKSLNLKCVSKVVNVNVDFKDFQFMLWCNEEKVMTF-----
| 2gti.1.A | Replicase polyprotein 1ab mutation of MHV coronavirus non-structural protein nsp15 (F307L) | 0.78 |  | 48.06 | 0.97 | 1-341 | X-ray | 2.15 | homo-hexamer |  | HHblits | 0.43
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2gti.1    SLENVVYNLVNAGHFDGRAGELPCAVIGEKVIAKIQNEDVVVFKNNTPFPTNVAVELFAKRSIRPHPELKLFRNLNIDVC

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2gti.1    WSHVLWDYAKDSVFCSSTYKVCKYTDLQC------IESLNVLFDGRDNGALEAFKKCRNGVYINTTKIKSLSMIKGPQRA

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLP---------------------------------ETYFTQSRNLQEFKPR
    2gti.1    DLNGVVVEKVGDSDVEFWFAVRKDGDDVIFSRTGSLEPSHYRSPQGNPGGNRVGDLSGNEALARGTIFTQSRLLSSFTPR

    target    SQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    2gti.1    SEMEKDFMDLDDDVFIAKYSLQDYAFEHVVYGSFNQKIIGGLHLLIGLARRQQKSNLVIQEFVTYDSSIHSYLITDENSG

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    2gti.1    SSKSVCTVIDLLLDDFVDIVKSLNLKCVSKVVNVNVDFKDFQFMLWCNEEKVMTF-----
| 4rs4.1.A | Uridylate-specific endoribonuclease Crystal structure and mutational analysis of the endoribonuclease from human coronavirus 229E | 0.74 |  | 45.67 | 0.97 | 2-346 | X-ray | 2.96 | homo-hexamer |  | BLAST | 0.41
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    4rs4.1    -LENIAFNVVNKGSFVSADGELPVAISGDKVFVRDGNTDNLVFVNKTSLPTNIAFELFAKRKVGLTPPLSILKNLGVVAT

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    4rs4.1    YKFVLWDYEAERPLTSFTKSVCGYTDFA----EDVCTC----YDNSIQGSYERFTLSTNAVLFSATAVKAGGKSL--PAI

    target    SLNGVTLIGEAVKT---------QFNY--YKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEG
    4rs4.1    KLNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDMGVFIQKYGLED

    target    YAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKS
    4rs4.1    FNFEHVVYGDVSKTTLGGLHLSISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKS

    target    QDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    4rs4.1    LDLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
| 4rs4.1.B | Uridylate-specific endoribonuclease Crystal structure and mutational analysis of the endoribonuclease from human coronavirus 229E | 0.74 |  | 45.67 | 0.97 | 2-346 | X-ray | 2.96 | homo-hexamer |  | BLAST | 0.41
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    4rs4.1    -LENIAFNVVNKGSFVSADGELPVAISGDKVFVRDGNTDNLVFVNKTSLPTNIAFELFAKRKVGLTPPLSILKNLGVVAT

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    4rs4.1    YKFVLWDYEAERPLTSFTKSVCGYTDFA----EDVCTC----YDNSIQGSYERFTLSTNAVLFSATAVKAGGKSL--PAI

    target    SLNGVTLIGEAVKT---------QFNY--YKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEG
    4rs4.1    KLNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDMGVFIQKYGLED

    target    YAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKS
    4rs4.1    FNFEHVVYGDVSKTTLGGLHLSISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKS

    target    QDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    4rs4.1    LDLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
| 4s1t.1.A | Uridylate-specific endoribonuclease Crystal structure of the mutant I26A/N52A of the endoribonuclease from human coronavirus 229E | 0.74 |  | 45.37 | 0.97 | 2-346 | X-ray | 2.50 | homo-hexamer |  | BLAST | 0.41
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    4s1t.1    -LENIAFNVVNKGSFVGADGELPVAASGDKVFVRDGNTDNLVFVNKTSLPTAIAFELFAKRKVGLTPPLSILKNLGVVAT

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    4s1t.1    YKFVLWDYEAERPLTSFTKSVCGYTDFA----EDVCTC----YDNSIQGSYERFTLSTNAVLFSATAVKTGGKSL--PAI

    target    SLNGVTLIGEAVKT---------QFNY--YKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEG
    4s1t.1    KLNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDIGVFIQKYGLED

    target    YAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKS
    4s1t.1    FNFEHVVYGDVSKTTLGGLHLLISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKS

    target    QDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    4s1t.1    LDLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
| 4rs4.1.A | Uridylate-specific endoribonuclease Crystal structure and mutational analysis of the endoribonuclease from human coronavirus 229E | 0.75 |  | 43.62 | 0.97 | 1-346 | X-ray | 2.96 | homo-hexamer |  | HHblits | 0.40
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    4rs4.1    GLENIAFNVVNKGSFVSADGELPVAISGDKVFVRDGNTDNLVFVNKTSLPTNIAFELFAKRKVGLTPPLSILKNLGVVAT

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVK----GLQPSVG
    4rs4.1    YKFVLWDYEAERPLTSFTKSVCGYTDFA--------EDVCTCYDNSIQGSYERFTLSTNAVLFSATAVKAGGKSLPAIK-

    target    PKQASLNGVTLIGE------AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGY
    4rs4.1    LNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDMGVFIQKYGLEDF

    target    AFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQ
    4rs4.1    NFEHVVYGDVSKTTLGGLHLSISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKSL

    target    DLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    4rs4.1    DLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
| 4rs4.1.B | Uridylate-specific endoribonuclease Crystal structure and mutational analysis of the endoribonuclease from human coronavirus 229E | 0.75 |  | 43.62 | 0.97 | 1-346 | X-ray | 2.96 | homo-hexamer |  | HHblits | 0.40
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    4rs4.1    GLENIAFNVVNKGSFVSADGELPVAISGDKVFVRDGNTDNLVFVNKTSLPTNIAFELFAKRKVGLTPPLSILKNLGVVAT

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVK----GLQPSVG
    4rs4.1    YKFVLWDYEAERPLTSFTKSVCGYTDFA--------EDVCTCYDNSIQGSYERFTLSTNAVLFSATAVKAGGKSLPAIK-

    target    PKQASLNGVTLIGE------AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGY
    4rs4.1    LNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDMGVFIQKYGLEDF

    target    AFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQ
    4rs4.1    NFEHVVYGDVSKTTLGGLHLSISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKSL

    target    DLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    4rs4.1    DLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
| 4s1t.1.A | Uridylate-specific endoribonuclease Crystal structure of the mutant I26A/N52A of the endoribonuclease from human coronavirus 229E | 0.75 |  | 43.32 | 0.97 | 1-346 | X-ray | 2.50 | homo-hexamer |  | HHblits | 0.40
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    4s1t.1    GLENIAFNVVNKGSFVGADGELPVAASGDKVFVRDGNTDNLVFVNKTSLPTAIAFELFAKRKVGLTPPLSILKNLGVVAT

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVK----GLQPSVG
    4s1t.1    YKFVLWDYEAERPLTSFTKSVCGYTDFA--------EDVCTCYDNSIQGSYERFTLSTNAVLFSATAVKTGGKSLPAIK-

    target    PKQASLNGVTLIGE------AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGY
    4s1t.1    LNFGMLNGNAIATVKSEDGNIKNINWFVYVRKDGKPVDHYDGFYTQGRNLQDFLPRSTMEEDFLNMDIGVFIQKYGLEDF

    target    AFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPM-DSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQ
    4s1t.1    NFEHVVYGDVSKTTLGGLHLLISQVRLSKMGILKAEEFVAASDITLKCCTVTYLNDPSSKTVCTYMDLLLDDFVSVLKSL

    target    DLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    4s1t.1    DLTVVSKVHEVIIDNKPWRWMLWCKDNAVATFYPQLQ
| 5wwp.1.A | ORF1ab Crystal structure of Middle East respiratory syndrome coronavirus helicase (MERS-CoV nsp13) | 0.24 |  | 11.60 | 0.72 | 24-346 | X-ray | 3.00 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5wwp.1    -----------------------CVVCHSQTSLRCGTCIRRPF-----LCCKCCYDHVIATPHKMVLSVSPYVCNAPGCG

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5wwp.1    VSDVTKLYLGGMSYFCVD-HRPVCSF--PLCA----N--------GLVFGLYKNMCTGSPSIVEFNRLATCDWTESGDYT

    target    --------GVLITEGSVKGL-QPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5wwp.1    LANTTTEPLKLFAAETLRATEEASK-QSYAIATIKEIVGERQLLLVWEAG------------------KSKPPLNRNYVF

    target    EIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSK
    5wwp.1    TGYHITK-----NSKVQLGEYIFERIDYSDAV-SYKSS-----TTYKLTV-----GDIFVLTSH-----SVATLTAPTIV

    target    CVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5wwp.1    NQERYVKITG-LYPTI-------TVPEEFASHVANF-----QKSGYSKYVTVQGPPG
| 5wwp.2.A | ORF1ab Crystal structure of Middle East respiratory syndrome coronavirus helicase (MERS-CoV nsp13) | 0.19 |  | 11.60 | 0.72 | 24-346 | X-ray | 3.00 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5wwp.2    -----------------------CVVCHSQTSLRCGTCIRRPF-----LCCKCCYDHVIATPHKMVLSVSPYVCNAPGCG

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5wwp.2    VSDVTKLYLGGMSYFCVD-HRPVCSF--PLCA----N--------GLVFGLYKNMCTGSPSIVEFNRLATCDWTESGDYT

    target    --------GVLITEGSVKGL-QPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5wwp.2    LANTTTEPLKLFAAETLRATEEASK-QSYAIATIKEIVGERQLLLVWEAG------------------KSKPPLNRNYVF

    target    EIDFLELAMDEFIERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSK
    5wwp.2    TGYHITK-----NSKVQLGEYIFERIDYSDAV-SYKSS-----TTYKLTV-----GDIFVLTSH-----SVATLTAPTIV

    target    CVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5wwp.2    NQERYVKITG-LYPTI-------TVPEEFASHVANF-----QKSGYSKYVTVQGPPG
| 5rob.2.A | Helicase PanDDA analysis group deposition of ground-state model of SARS-CoV-2 helicase | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.87 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rob.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rob.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rob.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rob.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rob.2    TLVPQEHYVRITG-----------------------------------------------
| 7nng.2.A | SARS-CoV-2 helicase NSP13 Crystal structure of the SARS-CoV-2 helicase in complex with Z2327226104 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.38 | monomer | 1 x UJK, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7nng.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7nng.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7nng.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7nng.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7nng.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlp.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z166605480 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.56 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlp.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlp.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlp.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlp.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlp.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlr.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z822382694 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.32 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlr.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlr.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlr.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlr.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlr.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlj.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1407673036 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.88 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlj.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlj.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlj.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlj.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlj.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlw.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z45705015 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.97 | monomer | 1 x S9S, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlw.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlw.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlw.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlw.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlw.1    TLVPQEHYVRITG-----------------------------------------------
| 5rl8.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53825177 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rl8.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rl8.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rl8.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rl8.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rl8.2    TLVPQEHYVRITG-----------------------------------------------
| 5rmc.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z24758179 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.15 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmc.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmc.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmc.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmc.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmc.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlc.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z56923284 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlc.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlc.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlc.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlc.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlc.1    TLVPQEHYVRITG-----------------------------------------------
| 5rmi.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53860899 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.12 | monomer | 1 x STV, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmi.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmi.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmi.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmi.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmi.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm0.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1492796719 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.91 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm0.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm0.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm0.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm0.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm0.1    TLVPQEHYVRITG-----------------------------------------------
| 5rl6.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z198195770 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rl6.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rl6.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rl6.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rl6.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rl6.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm2.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1741964527 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.82 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm2.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm2.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm2.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm2.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm2.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlv.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2467208649 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 2 x VWJ, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlv.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlv.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlv.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlv.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlv.1    TLVPQEHYVRITG-----------------------------------------------
| 5rmk.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1273312153 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmk.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmk.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmk.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmk.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmk.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlm.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1650168321 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.86 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlm.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlm.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlm.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlm.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlm.1    TLVPQEHYVRITG-----------------------------------------------
| 5rmd.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z57614330 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 1 x VWY, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmd.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmd.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmd.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmd.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmd.1    TLVPQEHYVRITG-----------------------------------------------
| 5rmj.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z68299550 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.10 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmj.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmj.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmj.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmj.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmj.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlh.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434778 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.38 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlh.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlh.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlh.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlh.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlh.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm4.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1639162606 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.96 | monomer | 1 x PK4, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm4.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm4.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm4.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm4.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm4.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlz.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2293643386 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.97 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlz.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlz.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlz.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlz.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlz.2    TLVPQEHYVRITG-----------------------------------------------
| 5rle.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1429867185 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.27 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rle.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rle.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rle.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rle.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rle.1    TLVPQEHYVRITG-----------------------------------------------
| 5rl9.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1703168683 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.79 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rl9.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rl9.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rl9.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rl9.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rl9.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlt.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53116498 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlt.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlt.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlt.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlt.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlt.1    TLVPQEHYVRITG-----------------------------------------------
| 5rll.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z425387594 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rll.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rll.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rll.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rll.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rll.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm3.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1745658474 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.09 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm3.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm3.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm3.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm3.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm3.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlo.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1454310449 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.10 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlo.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlo.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlo.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlo.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlo.1    TLVPQEHYVRITG-----------------------------------------------
| 5rli.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z45617795 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.26 | monomer | 1 x JFM, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rli.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rli.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rli.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rli.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rli.1    TLVPQEHYVRITG-----------------------------------------------
| 5rml.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z85956652 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 1 x VXD, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rml.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rml.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rml.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rml.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rml.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlb.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z216450634 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.98 | monomer | 1 x VVJ, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlb.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlb.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlb.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlb.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlb.1    TLVPQEHYVRITG-----------------------------------------------
| 5rld.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z19735981 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rld.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rld.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rld.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rld.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rld.1    TLVPQEHYVRITG-----------------------------------------------
| 5rln.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z364328788 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.15 | monomer | 1 x NZG, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rln.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rln.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rln.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rln.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rln.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm8.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1614545742 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.14 | monomer | 1 x GQJ, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm8.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm8.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm8.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm8.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm8.1    TLVPQEHYVRITG-----------------------------------------------
| 5rmm.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with POB0066 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.20 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmm.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmm.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmm.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmm.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmm.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm7.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z69118333 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.84 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm7.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm7.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm7.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm7.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm7.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm9.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434942 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm9.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm9.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm9.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm9.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm9.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlq.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z285782452 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 1 x UVA, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlq.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlq.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlq.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlq.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlq.1    TLVPQEHYVRITG-----------------------------------------------
| 5rmb.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434920 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 1 x VWV, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmb.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmb.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmb.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmb.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmb.1    TLVPQEHYVRITG-----------------------------------------------
| 5rmh.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1101755952 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.02 | monomer | 1 x VX4, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmh.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmh.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmh.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmh.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmh.1    TLVPQEHYVRITG-----------------------------------------------
| 5rl7.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z364321922 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.89 | monomer | 1 x VVD, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rl7.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rl7.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rl7.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rl7.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rl7.2    TLVPQEHYVRITG-----------------------------------------------
| 5rm1.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z426041412 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.90 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm1.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm1.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm1.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm1.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm1.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlu.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z744754722 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.35 | monomer | 1 x JG4, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlu.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlu.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlu.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlu.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlu.1    TLVPQEHYVRITG-----------------------------------------------
| 5rmg.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z285675722 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.12 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmg.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmg.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmg.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmg.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmg.1    TLVPQEHYVRITG-----------------------------------------------
| 5rme.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z26333434 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rme.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rme.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rme.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rme.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rme.2    TLVPQEHYVRITG-----------------------------------------------
| 5rm6.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z396380540 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.13 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm6.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm6.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm6.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm6.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm6.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlk.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1509882419 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.96 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlk.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlk.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlk.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlk.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlk.1    TLVPQEHYVRITG-----------------------------------------------
| 5rls.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z59181945 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.28 | monomer | 1 x VWG, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rls.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rls.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rls.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rls.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rls.1    TLVPQEHYVRITG-----------------------------------------------
| 5rma.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z321318226 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.89 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rma.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rma.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rma.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rma.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rma.1    TLVPQEHYVRITG-----------------------------------------------
| 5rly.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2027049478 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 1 x K34, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rly.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rly.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rly.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rly.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rly.1    TLVPQEHYVRITG-----------------------------------------------
| 5rmf.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z54226006 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 1 x NX7, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmf.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmf.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmf.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmf.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmf.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlg.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z19739650 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.96 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlg.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlg.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlg.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlg.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlg.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlf.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z235341991 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.24 | monomer | 1 x NY7, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlf.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlf.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlf.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlf.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlf.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm5.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z373768900 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.06 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm5.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm5.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm5.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm5.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm5.1    TLVPQEHYVRITG-----------------------------------------------
| 5rob.1.A | Helicase PanDDA analysis group deposition of ground-state model of SARS-CoV-2 helicase | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.87 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rob.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rob.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rob.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rob.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rob.1    TLVPQEHYVRITG-----------------------------------------------
| 7nng.1.A | SARS-CoV-2 helicase NSP13 Crystal structure of the SARS-CoV-2 helicase in complex with Z2327226104 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.38 | monomer | 1 x UJK, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7nng.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7nng.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7nng.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7nng.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7nng.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlw.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z45705015 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.97 | monomer | 1 x S9S, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlw.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlw.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlw.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlw.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlw.2    TLVPQEHYVRITG-----------------------------------------------
| 5rm7.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z69118333 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.84 | monomer | 1 x N0E, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm7.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm7.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm7.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm7.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm7.2    TLVPQEHYVRITG-----------------------------------------------
| 5rld.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z19735981 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 1 x VVY, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rld.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rld.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rld.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rld.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rld.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlk.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1509882419 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.96 | monomer | 1 x NYV, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlk.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlk.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlk.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlk.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlk.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlg.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z19739650 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.96 | monomer | 1 x VW1, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlg.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlg.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlg.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlg.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlg.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm8.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1614545742 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.14 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm8.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm8.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm8.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm8.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm8.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlp.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z166605480 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.56 | monomer | 1 x VWA, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlp.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlp.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlp.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlp.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlp.2    TLVPQEHYVRITG-----------------------------------------------
| 5rl6.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z198195770 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 1 x LJA, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rl6.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rl6.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rl6.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rl6.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rl6.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlc.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z56923284 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 1 x VVM, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlc.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlc.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlc.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlc.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlc.2    TLVPQEHYVRITG-----------------------------------------------
| 5rm9.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434942 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 1 x EJQ, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm9.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm9.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm9.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm9.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm9.2    TLVPQEHYVRITG-----------------------------------------------
| 5rm4.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1639162606 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.96 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm4.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm4.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm4.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm4.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm4.1    TLVPQEHYVRITG-----------------------------------------------
| 5rl9.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1703168683 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.79 | monomer | 1 x UR7, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rl9.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rl9.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rl9.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rl9.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rl9.2    TLVPQEHYVRITG-----------------------------------------------
| 5rmb.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434920 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmb.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmb.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmb.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmb.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmb.2    TLVPQEHYVRITG-----------------------------------------------
| 5rmc.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z24758179 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.15 | monomer | 1 x 6SU, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmc.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmc.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmc.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmc.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmc.2    TLVPQEHYVRITG-----------------------------------------------
| 5rmf.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z54226006 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmf.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmf.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmf.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmf.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmf.2    TLVPQEHYVRITG-----------------------------------------------
| 5rmj.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z68299550 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.10 | monomer | 1 x JOV, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmj.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmj.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmj.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmj.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmj.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm1.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z426041412 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.90 | monomer | 1 x RY4, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm1.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm1.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm1.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm1.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm1.2    TLVPQEHYVRITG-----------------------------------------------
| 5rmm.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with POB0066 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.20 | monomer | 1 x VXG, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmm.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmm.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmm.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmm.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmm.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlh.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2856434778 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.38 | monomer | 1 x K2P, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlh.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlh.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlh.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlh.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlh.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlq.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z285782452 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlq.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlq.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlq.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlq.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlq.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlj.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1407673036 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.88 | monomer | 1 x VW4, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlj.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlj.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlj.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlj.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlj.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlf.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z235341991 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.24 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlf.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlf.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlf.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlf.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlf.2    TLVPQEHYVRITG-----------------------------------------------
| 5rl8.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53825177 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 2 x VVG, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rl8.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rl8.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rl8.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rl8.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rl8.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm0.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1492796719 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.91 | monomer | 1 x S7G, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm0.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm0.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm0.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm0.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm0.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlt.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53116498 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 1 x UVJ, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlt.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlt.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlt.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlt.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlt.2    TLVPQEHYVRITG-----------------------------------------------
| 5rln.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z364328788 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.15 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rln.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rln.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rln.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rln.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rln.2    TLVPQEHYVRITG-----------------------------------------------
| 5rl7.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z364321922 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.89 | monomer | 1 x VVD, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rl7.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rl7.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rl7.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rl7.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rl7.1    TLVPQEHYVRITG-----------------------------------------------
| 5rlb.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z216450634 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.98 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlb.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlb.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlb.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlb.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlb.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlv.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2467208649 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.21 | monomer | 1 x VWJ, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlv.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlv.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlv.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlv.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlv.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlz.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2293643386 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.97 | monomer | 1 x VWM, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlz.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlz.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlz.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlz.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlz.1    TLVPQEHYVRITG-----------------------------------------------
| 5rmd.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z57614330 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.92 | monomer | 1 x VWY, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmd.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmd.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmd.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmd.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmd.2    TLVPQEHYVRITG-----------------------------------------------
| 5rll.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z425387594 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 1 x H04, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rll.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rll.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rll.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rll.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rll.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlo.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1454310449 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.10 | monomer | 1 x UQS, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlo.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlo.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlo.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlo.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlo.2    TLVPQEHYVRITG-----------------------------------------------
| 5rm5.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z373768900 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.06 | monomer | 1 x NUA, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm5.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm5.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm5.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm5.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm5.2    TLVPQEHYVRITG-----------------------------------------------
| 5rm6.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z396380540 | 0.19 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.13 | monomer | 1 x HR5, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm6.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm6.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm6.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm6.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm6.2    TLVPQEHYVRITG-----------------------------------------------
| 5rmh.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1101755952 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.02 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmh.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmh.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmh.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmh.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmh.2    TLVPQEHYVRITG-----------------------------------------------
| 5rli.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z45617795 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.26 | monomer | 2 x JFM, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rli.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rli.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rli.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rli.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rli.2    TLVPQEHYVRITG-----------------------------------------------
| 5rmk.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1273312153 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.08 | monomer | 1 x O2A, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmk.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmk.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmk.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmk.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmk.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlu.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z744754722 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.35 | monomer | 1 x JG4, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlu.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlu.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlu.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlu.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlu.2    TLVPQEHYVRITG-----------------------------------------------
| 5rme.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z26333434 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.23 | monomer | 1 x RYM, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rme.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rme.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rme.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rme.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rme.1    TLVPQEHYVRITG-----------------------------------------------
| 5rls.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z59181945 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.28 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rls.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rls.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rls.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rls.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rls.2    TLVPQEHYVRITG-----------------------------------------------
| 5rml.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z85956652 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rml.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rml.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rml.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rml.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rml.1    TLVPQEHYVRITG-----------------------------------------------
| 5rly.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z2027049478 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.43 | monomer | 2 x K34, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rly.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rly.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rly.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rly.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rly.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlr.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z822382694 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.32 | monomer | 1 x VWD, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlr.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlr.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlr.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlr.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlr.2    TLVPQEHYVRITG-----------------------------------------------
| 5rm3.1.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1745658474 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.09 | monomer | 1 x S7J, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm3.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm3.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm3.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm3.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm3.1    TLVPQEHYVRITG-----------------------------------------------
| 5rm2.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1741964527 | 0.16 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.82 | monomer | 2 x UXG, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rm2.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rm2.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rm2.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rm2.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rm2.2    TLVPQEHYVRITG-----------------------------------------------
| 5rma.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z321318226 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.89 | monomer | 1 x JHJ, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rma.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rma.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rma.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rma.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rma.2    TLVPQEHYVRITG-----------------------------------------------
| 5rlm.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1650168321 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.86 | monomer | 1 x VW7, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rlm.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rlm.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rlm.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rlm.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rlm.2    TLVPQEHYVRITG-----------------------------------------------
| 5rmg.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z285675722 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.12 | monomer | 1 x MUK, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmg.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmg.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmg.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmg.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmg.2    TLVPQEHYVRITG-----------------------------------------------
| 5rmi.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z53860899 | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.12 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rmi.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rmi.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rmi.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rmi.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rmi.2    TLVPQEHYVRITG-----------------------------------------------
| 5rle.2.A | Helicase PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 helicase in complex with Z1429867185 | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.27 | monomer | 1 x VVP, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    5rle.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    5rle.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    5rle.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    5rle.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5rle.2    TLVPQEHYVRITG-----------------------------------------------
| 7cxm.1.H | Helicase Architecture of a SARS-CoV-2 mini replication and transcription complex | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x U-A-A-A-A-U | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7cxm.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7cxm.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7cxm.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7cxm.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7cxm.1    TLVPQEHYVRITG-----------------------------------------------
| 7cxn.1.G | Helicase Architecture of a SARS-CoV-2 mini replication and transcription complex | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x U-A-A-A-A-U | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7cxn.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7cxn.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7cxn.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7cxn.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7cxn.1    TLVPQEHYVRITG-----------------------------------------------
| 7cxm.1.G | Helicase Architecture of a SARS-CoV-2 mini replication and transcription complex | 0.18 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x U-A-A-A-A-U | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7cxm.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7cxm.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7cxm.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7cxm.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7cxm.1    TLVPQEHYVRITG-----------------------------------------------
| 7cyq.1.H | Helicase Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in cap synthesis | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GDP, 1 x MG | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7cyq.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7cyq.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7cyq.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7cyq.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7cyq.1    TLVPQEHYVRITG-----------------------------------------------
| 7cyq.1.G | Helicase Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in cap synthesis | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GDP, 1 x MG | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7cyq.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7cyq.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7cyq.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7cyq.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7cyq.1    TLVPQEHYVRITG-----------------------------------------------
| 7cxn.1.H | Helicase Architecture of a SARS-CoV-2 mini replication and transcription complex | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x U-A-A-A-A-U | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7cxn.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7cxn.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7cxn.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7cxn.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7cxn.1    TLVPQEHYVRITG-----------------------------------------------
| 7egq.1.E | Helicase Co-transcriptional capping machineries in SARS-CoV-2 RTC: Coupling of N7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-2-2-… | 26 x ZN, 3 x MG | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7egq.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7egq.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7egq.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7egq.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7egq.1    TLVPQEHYVRITG-----------------------------------------------
| 7egq.1.Q | Helicase Co-transcriptional capping machineries in SARS-CoV-2 RTC: Coupling of N7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-2-2-… | 26 x ZN, 3 x MG | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7egq.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7egq.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7egq.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7egq.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7egq.1    TLVPQEHYVRITG-----------------------------------------------
| 7egq.1.R | Helicase Co-transcriptional capping machineries in SARS-CoV-2 RTC: Coupling of N7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-2-2-… | 26 x ZN, 3 x MG | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7egq.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7egq.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7egq.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7egq.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7egq.1    TLVPQEHYVRITG-----------------------------------------------
| 7egq.1.M | Helicase Co-transcriptional capping machineries in SARS-CoV-2 RTC: Coupling of N7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-2-2-… | 26 x ZN, 3 x MG | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7egq.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7egq.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7egq.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7egq.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7egq.1    TLVPQEHYVRITG-----------------------------------------------
| 7eiz.1.J | Helicase Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-1-1-1-… | 13 x ZN, 1 x MG | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7eiz.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7eiz.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7eiz.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7eiz.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7eiz.1    TLVPQEHYVRITG-----------------------------------------------
| 7eiz.1.K | Helicase Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-1-1-1-… | 13 x ZN, 1 x MG | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7eiz.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7eiz.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7eiz.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7eiz.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7eiz.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwo.1.H | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwo.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwo.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwo.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwo.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwo.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwb.1.H | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 2 x MN, 1 x A-U | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwb.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwb.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwb.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwb.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwb.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwo.1.G | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwo.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwo.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwo.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwo.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwo.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwb.1.G | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 2 x MN, 1 x A-U | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwb.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwb.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwb.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwb.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwb.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwi.1.H | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwi.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwi.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwi.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwi.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwi.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwg.1.H | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwg.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwg.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwg.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwg.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwg.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwf.1.H | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwf.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwf.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwf.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwf.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwf.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwe.1.H | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP, 1 x MG, 1 x A-U-U-A | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwe.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwe.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwe.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwe.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwe.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwi.1.G | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwi.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwi.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwi.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwi.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwi.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwg.1.G | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwg.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwg.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwg.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwg.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwg.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwf.1.G | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GTP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwf.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwf.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwf.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwf.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwf.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwe.1.G | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP, 1 x MG, 1 x A-U-U-A | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwe.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwe.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwe.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwe.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwe.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwn.1.H | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwn.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwn.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwn.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwn.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwn.1    TLVPQEHYVRITG-----------------------------------------------
| 8gwn.1.G | Helicase A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analogue inhibitors | 0.17 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-1-mer | 8 x ZN, 1 x GNP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    8gwn.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    8gwn.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    8gwn.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    8gwn.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8gwn.1    TLVPQEHYVRITG-----------------------------------------------
| 6jyt.1.A | Helicase Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis | 0.19 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.80 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    6jyt.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    6jyt.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    6jyt.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    6jyt.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    6jyt.1    TLVPQEHYVRITG-----------------------------------------------
| 6jyt.2.A | Helicase Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.80 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    6jyt.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    6jyt.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    6jyt.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    6jyt.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    6jyt.2    TLVPQEHYVRITG-----------------------------------------------
| 7nio.1.B | SARS-CoV-2 helicase NSP13 Crystal structure of the SARS-CoV-2 helicase APO form | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.20 | homo-dimer | 6 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7nio.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7nio.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7nio.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7nio.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7nio.1    TLVPQEHYVRITG-----------------------------------------------
| 7nio.1.A | SARS-CoV-2 helicase NSP13 Crystal structure of the SARS-CoV-2 helicase APO form | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 2.20 | homo-dimer | 6 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7nio.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7nio.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7nio.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7nio.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7nio.1    TLVPQEHYVRITG-----------------------------------------------
| 7nn0.3.A | SARS-CoV-2 helicase NSP13 Crystal structure of the SARS-CoV-2 helicase in complex with AMP-PNP | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 3.04 | monomer | 3 x ZN, 1 x ANP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7nn0.3    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7nn0.3    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7nn0.3    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7nn0.3    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7nn0.3    TLVPQEHYVRITG-----------------------------------------------
| 7nn0.1.A | SARS-CoV-2 helicase NSP13 Crystal structure of the SARS-CoV-2 helicase in complex with AMP-PNP | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 3.04 | monomer | 1 x ANP, 3 x ZN, 1 x MG | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7nn0.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7nn0.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7nn0.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7nn0.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7nn0.1    TLVPQEHYVRITG-----------------------------------------------
| 7nn0.4.A | SARS-CoV-2 helicase NSP13 Crystal structure of the SARS-CoV-2 helicase in complex with AMP-PNP | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 3.04 | monomer | 3 x ZN, 1 x ANP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7nn0.4    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7nn0.4    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7nn0.4    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7nn0.4    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7nn0.4    TLVPQEHYVRITG-----------------------------------------------
| 6zsl.1.A | SARS-CoV-2 helicase NSP13 Crystal structure of the SARS-CoV-2 helicase at 1.94 Angstrom resolution | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.94 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    6zsl.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    6zsl.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    6zsl.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    6zsl.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    6zsl.1    TLVPQEHYVRITG-----------------------------------------------
| 6zsl.2.A | SARS-CoV-2 helicase NSP13 Crystal structure of the SARS-CoV-2 helicase at 1.94 Angstrom resolution | 0.17 |  | 11.27 | 0.62 | 24-299 | X-ray | 1.94 | monomer | 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    6zsl.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    6zsl.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    6zsl.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    6zsl.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    6zsl.2    TLVPQEHYVRITG-----------------------------------------------
| 7nn0.2.A | SARS-CoV-2 helicase NSP13 Crystal structure of the SARS-CoV-2 helicase in complex with AMP-PNP | 0.18 |  | 11.27 | 0.62 | 24-299 | X-ray | 3.04 | monomer | 1 x ANP, 3 x ZN | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7nn0.2    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7nn0.2    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7nn0.2    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7nn0.2    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7nn0.2    TLVPQEHYVRITG-----------------------------------------------
| 7kro.1.F | Helicase Structure of SARS-CoV-2 backtracked complex complex bound to nsp13 helicase - nsp13(2)-BTC | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7kro.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7kro.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7kro.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7kro.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7kro.1    TLVPQEHYVRITG-----------------------------------------------
| 7kro.1.E | Helicase Structure of SARS-CoV-2 backtracked complex complex bound to nsp13 helicase - nsp13(2)-BTC | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7kro.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7kro.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7kro.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7kro.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7kro.1    TLVPQEHYVRITG-----------------------------------------------
| 6xez.1.E | Helicase Structure of SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    6xez.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    6xez.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    6xez.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    6xez.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    6xez.1    TLVPQEHYVRITG-----------------------------------------------
| 6xez.1.F | Helicase Structure of SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    6xez.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    6xez.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    6xez.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    6xez.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    6xez.1    TLVPQEHYVRITG-----------------------------------------------
| 7krn.1.E | Helicase Structure of SARS-CoV-2 backtracked complex bound to nsp13 helicase - nsp13(1)-BTC | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-1-mer | 5 x ZN, 2 x MG, 2 x ADP, 3 x 1N7, 1 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7krn.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7krn.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7krn.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7krn.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7krn.1    TLVPQEHYVRITG-----------------------------------------------
| 7re1.1.F | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC (composite) | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7re1.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7re1.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7re1.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7re1.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7re1.1    TLVPQEHYVRITG-----------------------------------------------
| 7rdz.1.E | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - apo class | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x MG, 1 x ADP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7rdz.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7rdz.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7rdz.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7rdz.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7rdz.1    TLVPQEHYVRITG-----------------------------------------------
| 7re3.1.N | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC dimer | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-mer | 16 x ZN, 6 x MG, 6 x ADP, 4 x AF3, 2 x 1N7 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7re3.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7re3.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7re3.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7re3.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7re3.1    TLVPQEHYVRITG-----------------------------------------------
| 7re3.1.F | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC dimer | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-mer | 16 x ZN, 6 x MG, 6 x ADP, 4 x AF3, 2 x 1N7 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7re3.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7re3.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7re3.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7re3.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7re3.1    TLVPQEHYVRITG-----------------------------------------------
| 7re0.1.E | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - swiveled class | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7re0.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7re0.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7re0.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7re0.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7re0.1    TLVPQEHYVRITG-----------------------------------------------
| 7rdy.1.F | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - engaged class | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7rdy.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7rdy.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7rdy.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7rdy.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7rdy.1    TLVPQEHYVRITG-----------------------------------------------
| 7re3.1.M | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC dimer | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-mer | 16 x ZN, 6 x MG, 6 x ADP, 4 x AF3, 2 x 1N7 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7re3.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7re3.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7re3.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7re3.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7re3.1    TLVPQEHYVRITG-----------------------------------------------
| 7re3.1.E | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC dimer | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-2-4-2-4-mer | 16 x ZN, 6 x MG, 6 x ADP, 4 x AF3, 2 x 1N7 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7re3.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7re3.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7re3.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7re3.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7re3.1    TLVPQEHYVRITG-----------------------------------------------
| 7re2.1.E | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(1)-RTC | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-1-mer | 5 x ZN, 2 x MG, 2 x ADP, 3 x 1N7, 1 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7re2.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7re2.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7re2.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7re2.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7re2.1    TLVPQEHYVRITG-----------------------------------------------
| 7rdy.1.E | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - engaged class | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7rdy.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7rdy.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7rdy.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7rdy.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7rdy.1    TLVPQEHYVRITG-----------------------------------------------
| 7rdz.1.F | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - apo class | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 1 x MG, 1 x ADP | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7rdz.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7rdz.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7rdz.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7rdz.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7rdz.1    TLVPQEHYVRITG-----------------------------------------------
| 7re1.1.E | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC (composite) | 0.20 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7re1.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7re1.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7re1.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7re1.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7re1.1    TLVPQEHYVRITG-----------------------------------------------
| 7rdx.1.E | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - open class | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7rdx.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7rdx.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7rdx.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7rdx.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7rdx.1    TLVPQEHYVRITG-----------------------------------------------
| 7re0.1.F | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - swiveled class | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7re0.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7re0.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7re0.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7re0.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7re0.1    TLVPQEHYVRITG-----------------------------------------------
| 7rdx.1.F | Helicase SARS-CoV-2 replication-transcription complex bound to nsp13 helicase - nsp13(2)-RTC - open class | 0.19 |  | 11.27 | 0.62 | 24-299 | EM | 0.00 | hetero-1-2-1-2-mer | 8 x ZN, 3 x MG, 3 x ADP, 3 x 1N7, 2 x AF3 | HHblits | 0.25
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWA----KRNIKPVPEVKILNNLG
    7rdx.1    -----------------------CVLCNSQTSLRCGACIRRPF-----LCCKCCYDHVISTSHKLVLSVNPYVCNAPGCD

    target    VDIAANT-----VIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARN------------
    7rdx.1    VTDVTQLYLGGMSYYCKS-HKPPISF--PLCA----N--------GQVFGLYKNTCVGSDNVTDFNAIATCDWTNAGDYI

    target    --------GVLITEGSVKG-LQPSVGPKQASLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQM
    7rdx.1    LANTCTERLKLFAAETLKATEETFK-LSYGIATVREVLSDRELHLSWEVG------------------------KPRPPL

    target    EIDFLELAMDEF---IERYKLEGYAFEHIVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG
    7rdx.1    NRNYVF--TGYRVTKNSKVQIGEYTFEKGDYGDAV-VYRGT-----TTYKLN-----VGDYFVLT-----SHTVMPLSAP

    target    SSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    7rdx.1    TLVPQEHYVRITG-----------------------------------------------
| 8g6r.1.A | nsp12 Porcine epidemic diarrhea virus core polymerase complex | 0.15 |  | 7.48 | 0.62 | 22-325 | EM | 0.00 | hetero-1-1-1-mer | 2 x ZN | HHblits | 0.24
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNT-----VYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNL
    8g6r.1    ---------------------IVGVVTLDNQDLNGDFYDFGDFTCSIKGMGIPICTS--YYSYMMPVMGMTN--CLASEC

    target    GVDIA-------------------------ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQ
    8g6r.1    FVKSDIFGEDFKSYDLLEYDFTEHKTALFNKYFKYWGLQYHPNCVDCSDEQCIVH--------------CANFNTLFSTT

    target    VDLFRNARN------------------------------------------GVLITEGSVK----------GLQPS---V
    8g6r.1    IPITAFGPLCRKCWIDGVPLVTTAGYHFKQLGIVWNNDLNLHSSRLSINELLQFCSDPALLIASSPALVDQRTVCFSVAA

    target    GPKQASLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHI
    8g6r.1    -LGTGMTNQT-VKPGHFNKEFYDFLLE--------QGFFSEGSEL-------TLKHFFFAQK-----GDAAVKDFDYY--

    target    VYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVS
    8g6r.1    RYNRPT-------VLDICQARVVY-----------------------------QIVQRYFDIYEGGCIT-----------

    target    KVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    8g6r.1    -AKEVVVTNL---------------------
| 5f17.1.A | Non-structural protein 11 Structure of EAV NSP11 K170A mutant at 3.19A | 0.29 |  | 22.86 | 0.51 | 135-344 | X-ray | 3.20 | homo-dimer |  | HHblits | 0.32
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5f17.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5f17.1    ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5f17.1    YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5f17.1    EINKSTVGGSHFIFSQYLPPL---------LPA-DAVALVGAS-LAGKAAAAACSVVDVYAPSFEPYLHP---ETLSRVY

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5f17.1    KIMIDFKPCRLMVWRNA----TFYVQ--
| 5f17.1.B | Non-structural protein 11 Structure of EAV NSP11 K170A mutant at 3.19A | 0.25 |  | 22.86 | 0.51 | 135-344 | X-ray | 3.20 | homo-dimer |  | HHblits | 0.32
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5f17.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5f17.1    ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5f17.1    YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5f17.1    EINKSTVGGSHFIFSQYLPPL---------LPA-DAVALVGAS-LAGKAAAAACSVVDVYAPSFEPYLHP---ETLSRVY

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5f17.1    KIMIDFKPCRLMVWRNA----TFYVQ--
| 5eyi.1.A | Non-structural protein 11 Structure of PRRSV apo-NSP11 at 2.16A | 0.29 |  | 19.10 | 0.51 | 135-346 | X-ray | 2.16 | homo-dimer |  | HHblits | 0.30
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5eyi.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5eyi.1    ------------------------------------------------------EKWPDRLVASLRPIHKYSRAC-IGAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5eyi.1    YMVGPSVFLGTPGVVSYYLTKFVKGEAQLLPETVFSTGRIEVDCREYLDDREREVAA---------------SLPHAFIG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5eyi.1    DVKGTTVGGCHHVTSRYLPRVL---PKE-------SVAVVGVS-SPGKAAAALCTLTDVYLPDLEAYLHP---ETQSKCW

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5eyi.1    KMMLDFKEVRLMVWRDK----TAYFQLE
| 5eyi.1.B | Non-structural protein 11 Structure of PRRSV apo-NSP11 at 2.16A | 0.25 |  | 19.10 | 0.51 | 135-346 | X-ray | 2.16 | homo-dimer |  | HHblits | 0.30
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5eyi.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5eyi.1    ------------------------------------------------------EKWPDRLVASLRPIHKYSRAC-IGAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5eyi.1    YMVGPSVFLGTPGVVSYYLTKFVKGEAQLLPETVFSTGRIEVDCREYLDDREREVAA---------------SLPHAFIG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5eyi.1    DVKGTTVGGCHHVTSRYLPRVL---PKE-------SVAVVGVS-SPGKAAAALCTLTDVYLPDLEAYLHP---ETQSKCW

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5eyi.1    KMMLDFKEVRLMVWRDK----TAYFQLE
| 5hbz.1.A | Non-structural protein 11 Structure of EAV NSP11 K170A mutant at 3.10A | 0.28 |  | 22.99 | 0.50 | 136-344 | X-ray | 3.10 | homo-dimer |  | HHblits | 0.32
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5hbz.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5hbz.1    -------------------------------------------------------RYPNCLQITLQQVCELSKPC--SAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5hbz.1    YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5hbz.1    EINKSTVGGSHFIFSQYLPPL---------LPA-DAVALVGAS-LAGKAAAAACSVVDVYAPSFEPYLHP---ETLSRVY

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5hbz.1    KIMIDFKPCRLMVWRNA----TFYVQ--
| 5hbz.1.B | Non-structural protein 11 Structure of EAV NSP11 K170A mutant at 3.10A | 0.24 |  | 22.99 | 0.50 | 136-344 | X-ray | 3.10 | homo-dimer |  | HHblits | 0.32
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5hbz.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5hbz.1    -------------------------------------------------------RYPNCLQITLQQVCELSKPC--SAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5hbz.1    YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5hbz.1    EINKSTVGGSHFIFSQYLPPL---------LPA-DAVALVGAS-LAGKAAAAACSVVDVYAPSFEPYLHP---ETLSRVY

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5hbz.1    KIMIDFKPCRLMVWRNA----TFYVQ--
| 5hc1.1.A | Non-structural protein 11 Structure of EAV NSP11 H141A mutant at 3.10A | 0.27 |  | 22.29 | 0.51 | 135-344 | X-ray | 3.10 | homo-dimer |  | HHblits | 0.31
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5hc1.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5hc1.1    ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5hc1.1    YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5hc1.1    EINKSTVGGSAFIFSQYLPPLL---PA-------DAVALVGAS-LAGKAAKAACSVVDVYAPSFEPYLHP---ETLSRVY

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5hc1.1    KIMIDFKPCRLMVWRNA----TFYVQ--
| 5hc1.1.B | Non-structural protein 11 Structure of EAV NSP11 H141A mutant at 3.10A | 0.27 |  | 22.29 | 0.51 | 135-344 | X-ray | 3.10 | homo-dimer |  | HHblits | 0.31
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5hc1.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5hc1.1    ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5hc1.1    YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5hc1.1    EINKSTVGGSAFIFSQYLPPLL---PA-------DAVALVGAS-LAGKAAKAACSVVDVYAPSFEPYLHP---ETLSRVY

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5hc1.1    KIMIDFKPCRLMVWRNA----TFYVQ--
| 5hc1.2.A | Non-structural protein 11 Structure of EAV NSP11 H141A mutant at 3.10A | 0.26 |  | 22.29 | 0.51 | 135-344 | X-ray | 3.10 | homo-dimer |  | HHblits | 0.31
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5hc1.2    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5hc1.2    ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5hc1.2    YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5hc1.2    EINKSTVGGSAFIFSQYLPPLL---PA-------DAVALVGAS-LAGKAAKAACSVVDVYAPSFEPYLHP---ETLSRVY

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5hc1.2    KIMIDFKPCRLMVWRNA----TFYVQ--
| 5hc1.2.B | Non-structural protein 11 Structure of EAV NSP11 H141A mutant at 3.10A | 0.25 |  | 22.29 | 0.51 | 135-344 | X-ray | 3.10 | homo-dimer |  | HHblits | 0.31
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5hc1.2    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5hc1.2    ------------------------------------------------------DRYPNCLQITLQQVCELSKPC--SAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5hc1.2    YMVGQSVFVQTPGVTSYWLTEWVDGKARALPDSLFSSGRFETNSRAFLDEAEEKFAA---------------AHPHACLG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5hc1.2    EINKSTVGGSAFIFSQYLPPLL---PA-------DAVALVGAS-LAGKAAKAACSVVDVYAPSFEPYLHP---ETLSRVY

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5hc1.2    KIMIDFKPCRLMVWRNA----TFYVQ--
| 5da1.1.A | endoribonuclease A Dimerization-Dependent Mechanism Drives PRRSV NSP11 Functions As a Beta Interferon Antagonist and Endoribonuclease | 0.27 |  | 19.21 | 0.51 | 135-341 | X-ray | 2.75 | homo-dimer |  | HHblits | 0.30
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5da1.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5da1.1    ------------------------------------------------------ERWPDRLVASLRPIHKYSRAC-IGAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5da1.1    YMVGPSVFLGTPGVVSYYLTKFVRGEAQVLPETVFSTGRIEVDCREYLDDRERVVAE---------------SLPHAFIG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5da1.1    DVKGTTVGGCHHVTSKYLPRFL---PKE-------SVAVVGV-SSPGKAAKAVCTLTDVYLPDLEAYLHPE---TQSRCW

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5da1.1    KVMLDFKEVRLMVWKDKTAYFQL-----
| 5da1.1.B | endoribonuclease A Dimerization-Dependent Mechanism Drives PRRSV NSP11 Functions As a Beta Interferon Antagonist and Endoribonuclease | 0.25 |  | 19.21 | 0.51 | 135-341 | X-ray | 2.75 | homo-dimer |  | HHblits | 0.30
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5da1.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5da1.1    ------------------------------------------------------ERWPDRLVASLRPIHKYSRAC-IGAG

    target    SLNGVTLIGE-AVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRS-QMEIDFLELAMDEFIERYKLEGYAFEHIVYG
    5da1.1    YMVGPSVFLGTPGVVSYYLTKFVRGEAQVLPETVFSTGRIEVDCREYLDDRERVVAE---------------SLPHAFIG

    target    DFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVV
    5da1.1    DVKGTTVGGCHHVTSKYLPRFL---PKE-------SVAVVGV-SSPGKAAKAVCTLTDVYLPDLEAYLHPE---TQSRCW

    target    KVTIDYTEISFMLWCKDGHVETFYPKLQ
    5da1.1    KVMLDFKEVRLMVWKDKTAYFQL-----
| 5da1.1.A | endoribonuclease A Dimerization-Dependent Mechanism Drives PRRSV NSP11 Functions As a Beta Interferon Antagonist and Endoribonuclease | 0.17 |  | 30.13 | 0.45 | 148-332 | X-ray | 2.75 | homo-dimer |  | BLAST | 0.36
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5da1.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5da1.1    -------------------------------------------------------------------VASLRPIHKYSRA

    target    SLNGVTLIGEAV----KTQFNYY--KKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEH
    5da1.1    CIGAGYMVGPSVFLGTPGVVSYYLTKFVRGEAQVLPETVFSTGR----------IEVDCREYLDD----RERVVAESLPH

    target    IVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG-SSKCVCSVIDLLLDDFVEIIKSQDLSV
    5da1.1    AFIGDVKGTTVGGCHHVTSKY---------LPRFLPKESVA---VVGVSSPGKAAKAVCTLTDVYLPDLEAYLHPE---T

    target    VSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5da1.1    QSRCWKVMLDFKEVRLMVW--------------
| 5da1.1.B | endoribonuclease A Dimerization-Dependent Mechanism Drives PRRSV NSP11 Functions As a Beta Interferon Antagonist and Endoribonuclease | 0.15 |  | 30.13 | 0.45 | 148-332 | X-ray | 2.75 | homo-dimer |  | BLAST | 0.36
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    5da1.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    5da1.1    -------------------------------------------------------------------VASLRPIHKYSRA

    target    SLNGVTLIGEAV----KTQFNYY--KKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEH
    5da1.1    CIGAGYMVGPSVFLGTPGVVSYYLTKFVRGEAQVLPETVFSTGR----------IEVDCREYLDD----RERVVAESLPH

    target    IVYGDFSHSQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTG-SSKCVCSVIDLLLDDFVEIIKSQDLSV
    5da1.1    AFIGDVKGTTVGGCHHVTSKY---------LPRFLPKESVA---VVGVSSPGKAAKAVCTLTDVYLPDLEAYLHPE---T

    target    VSKVVKVTIDYTEISFMLWCKDGHVETFYPKLQ
    5da1.1    QSRCWKVMLDFKEVRLMVW--------------
| 2c1w.1.A | ENDOU PROTEIN THE STRUCTURE OF XENDOU: A SPLICING INDEPENDENT SNORNA PROCESSING ENDORIBONUCLEASE | 0.01 |  | 19.05 | 0.12 | 228-269 | X-ray | 2.20 | monomer |  | HHblits | 0.34
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2c1w.1    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2c1w.1    --------------------------------------------------------------------------------

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    2c1w.1    -------------------------------------------------------------------DSCGFEHVFVGES

    target    SH-SQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVK
    2c1w.1    KRGQEMMGLHNWVQFYLQEKRKNIDYKGYV--------------------------------------------------

    target    VTIDYTEISFMLWCKDGHVETFYPKLQ
    2c1w.1    ---------------------------
| 2c1w.2.A | ENDOU PROTEIN THE STRUCTURE OF XENDOU: A SPLICING INDEPENDENT SNORNA PROCESSING ENDORIBONUCLEASE | 0.01 |  | 19.05 | 0.12 | 228-269 | X-ray | 2.20 | monomer |  | HHblits | 0.34
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2c1w.2    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2c1w.2    --------------------------------------------------------------------------------

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    2c1w.2    -------------------------------------------------------------------DSCGFEHVFVGES

    target    SH-SQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVK
    2c1w.2    KRGQEMMGLHNWVQFYLQEKRKNIDYKGYV--------------------------------------------------

    target    VTIDYTEISFMLWCKDGHVETFYPKLQ
    2c1w.2    ---------------------------
| 2c1w.3.A | ENDOU PROTEIN THE STRUCTURE OF XENDOU: A SPLICING INDEPENDENT SNORNA PROCESSING ENDORIBONUCLEASE | 0.01 |  | 19.05 | 0.12 | 228-269 | X-ray | 2.20 | monomer |  | HHblits | 0.34
    target    SLENVAFNVVNKGHFDGQQGEVPVSIINNTVYTKVDGVDVELFENKTTLPVNVAFELWAKRNIKPVPEVKILNNLGVDIA
    2c1w.3    --------------------------------------------------------------------------------

    target    ANTVIWDYKRDAPAHISTIGVCSMTDIAKKPTETICAPLTVFFDGRVDGQVDLFRNARNGVLITEGSVKGLQPSVGPKQA
    2c1w.3    --------------------------------------------------------------------------------

    target    SLNGVTLIGEAVKTQFNYYKKVDGVVQQLPETYFTQSRNLQEFKPRSQMEIDFLELAMDEFIERYKLEGYAFEHIVYGDF
    2c1w.3    -------------------------------------------------------------------DSCGFEHVFVGES

    target    SH-SQLGGLHLLIGLAKRFKESPFELEDFIPMDSTVKNYFITDAQTGSSKCVCSVIDLLLDDFVEIIKSQDLSVVSKVVK
    2c1w.3    KRGQEMMGLHNWVQFYLQEKRKNIDYKGYV--------------------------------------------------

    target    VTIDYTEISFMLWCKDGHVETFYPKLQ
    2c1w.3    ---------------------------